These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. Leese MP; Jourdan FL; Gaukroger K; Mahon MF; Newman SP; Foster PA; Stengel C; Regis-Lydi S; Ferrandis E; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV J Med Chem; 2008 Mar; 51(5):1295-308. PubMed ID: 18260615 [TBL] [Abstract][Full Text] [Related]
3. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. Leese MP; Leblond B; Smith A; Newman SP; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV J Med Chem; 2006 Dec; 49(26):7683-96. PubMed ID: 17181151 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Ghorab MM; Ragab FA; Hamed MM Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629 [TBL] [Abstract][Full Text] [Related]
6. Out of the active site binding pocket for carbonic anhydrase inhibitors. D'Ambrosio K; Carradori S; Monti SM; Buonanno M; Secci D; Vullo D; Supuran CT; De Simone G Chem Commun (Camb); 2015; 51(2):302-5. PubMed ID: 25407638 [TBL] [Abstract][Full Text] [Related]
7. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172 [TBL] [Abstract][Full Text] [Related]
8. Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors. Scott AD; Phillips C; Alex A; Flocco M; Bent A; Randall A; O'Brien R; Damian L; Jones LH ChemMedChem; 2009 Dec; 4(12):1985-9. PubMed ID: 19882701 [No Abstract] [Full Text] [Related]
9. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Temperini C; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709 [TBL] [Abstract][Full Text] [Related]
11. In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Mocharla VP; Colasson B; Lee LV; Röper S; Sharpless KB; Wong CH; Kolb HC Angew Chem Int Ed Engl; 2004 Dec; 44(1):116-20. PubMed ID: 15599912 [No Abstract] [Full Text] [Related]
12. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity. Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Yenikaya C; Sari M; Bülbül M; Ilkimen H; Celik H; Büyükgüngör O Bioorg Med Chem; 2010 Jan; 18(2):930-8. PubMed ID: 20006931 [TBL] [Abstract][Full Text] [Related]
14. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents. Agrawal VK; Bano S; Supuran CT; Khadikar PV Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment. Yamashita A; Norton EB; Kaplan JA; Niu C; Loganzo F; Hernandez R; Beyer CF; Annable T; Musto S; Discafani C; Zask A; Ayral-Kaloustian S Bioorg Med Chem Lett; 2004 Nov; 14(21):5317-22. PubMed ID: 15454219 [TBL] [Abstract][Full Text] [Related]
16. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
17. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer. Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501 [TBL] [Abstract][Full Text] [Related]
18. Arylthioindoles, potent inhibitors of tubulin polymerization. De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282 [TBL] [Abstract][Full Text] [Related]
19. Analysis of human carbonic anhydrase II: docking reliability and receptor-based 3D-QSAR study. Tuccinardi T; Nuti E; Ortore G; Supuran CT; Rossello A; Martinelli A J Chem Inf Model; 2007; 47(2):515-25. PubMed ID: 17295464 [TBL] [Abstract][Full Text] [Related]
20. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Dudutiene V; Baranauskiene L; Matulis D Bioorg Med Chem Lett; 2007 Jun; 17(12):3335-8. PubMed ID: 17442568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]